View in EDS HTML Full Text PDF Full Text

Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.

Saved in:
Bibliographic Details
Title: Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
Authors: Park SH; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France., Farooq MA; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France., Gaertner S; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.; Hôpitaux Universitaires de Strasbourg, Service des Maladies Vasculaires - Hypertension Artérielle, Strasbourg, France., Bruckert C; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France., Qureshi AW; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France., Lee HH; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France., Benrahla D; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France., Pollet B; UMR CNRS 7021 Laboratoire de Bioimagerie et Pathologies, Strasbourg, France., Stephan D; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.; Hôpitaux Universitaires de Strasbourg, Service des Maladies Vasculaires - Hypertension Artérielle, Strasbourg, France., Ohlmann P; Hôpitaux Universitaires de Strasbourg, Service de Cardiologie, Strasbourg, France., Lessinger JM; Laboratory of Biochemistry and Molecular Biology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Mayoux E; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Auger C; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France., Morel O; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.; Hôpitaux Universitaires de Strasbourg, Service de Cardiologie, Strasbourg, France., Schini-Kerth VB; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France. valerie.schini-kerth@unistra.fr.
Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2020 Feb 18; Vol. 19 (1), pp. 19. Date of Electronic Publication: 2020 Feb 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32070346
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Park+SH%22">Park SH</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Farooq+MA%22">Farooq MA</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Gaertner+S%22">Gaertner S</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.; Hôpitaux Universitaires de Strasbourg, Service des Maladies Vasculaires - Hypertension Artérielle, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Bruckert+C%22">Bruckert C</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Qureshi+AW%22">Qureshi AW</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Lee+HH%22">Lee HH</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Benrahla+D%22">Benrahla D</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Pollet+B%22">Pollet B</searchLink>; UMR CNRS 7021 Laboratoire de Bioimagerie et Pathologies, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Stephan+D%22">Stephan D</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.; Hôpitaux Universitaires de Strasbourg, Service des Maladies Vasculaires - Hypertension Artérielle, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Ohlmann+P%22">Ohlmann P</searchLink>; Hôpitaux Universitaires de Strasbourg, Service de Cardiologie, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Lessinger+JM%22">Lessinger JM</searchLink>; Laboratory of Biochemistry and Molecular Biology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Mayoux+E%22">Mayoux E</searchLink>; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.<br /><searchLink fieldCode="AU" term="%22Auger+C%22">Auger C</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Morel+O%22">Morel O</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.; Hôpitaux Universitaires de Strasbourg, Service de Cardiologie, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Schini-Kerth+VB%22">Schini-Kerth VB</searchLink>; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France. valerie.schini-kerth@unistra.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101147637%22">Cardiovascular diabetology</searchLink> [Cardiovasc Diabetol] 2020 Feb 18; Vol. 19 (1), pp. 19. <i>Date of Electronic Publication: </i>2020 Feb 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101147637 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1475-2840 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214752840%22">14752840 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Diabetol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32070346
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12933-020-00997-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 19
    Titles:
      – TitleFull: Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Park SH
      – PersonEntity:
          Name:
            NameFull: Farooq MA
      – PersonEntity:
          Name:
            NameFull: Gaertner S
      – PersonEntity:
          Name:
            NameFull: Bruckert C
      – PersonEntity:
          Name:
            NameFull: Qureshi AW
      – PersonEntity:
          Name:
            NameFull: Lee HH
      – PersonEntity:
          Name:
            NameFull: Benrahla D
      – PersonEntity:
          Name:
            NameFull: Pollet B
      – PersonEntity:
          Name:
            NameFull: Stephan D
      – PersonEntity:
          Name:
            NameFull: Ohlmann P
      – PersonEntity:
          Name:
            NameFull: Lessinger JM
      – PersonEntity:
          Name:
            NameFull: Mayoux E
      – PersonEntity:
          Name:
            NameFull: Auger C
      – PersonEntity:
          Name:
            NameFull: Morel O
      – PersonEntity:
          Name:
            NameFull: Schini-Kerth VB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 02
              Text: 2020 Feb 18
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1475-2840
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cardiovascular diabetology
              Type: main
ResultId 1